Brooke GN - Search Results

1

The role of the p90 ribosomal S6 kinase family in prostate cancer progression and therapy resistance.

Cronin R, Brooke GN, Prischi F. Cronin R, et al. Among authors: brooke gn. Oncogene. 2021 Jun;40(22):3775-3785. doi: 10.1038/s41388-021-01810-9. Epub 2021 May 10. Oncogene. 2021. PMID: 33972681 Free PMC article. Review.

2

Mechanisms of androgen receptor activation in advanced prostate cancer: differential co-activator recruitment and gene expression.

Brooke GN, Parker MG, Bevan CL. Brooke GN, et al. Oncogene. 2008 May 8;27(21):2941-50. doi: 10.1038/sj.onc.1210955. Epub 2007 Nov 26. Oncogene. 2008. PMID: 18037956 Free article.

3

Reducing prohibitin increases histone acetylation, and promotes androgen independence in prostate tumours by increasing androgen receptor activation by adrenal androgens.

Dart DA, Brooke GN, Sita-Lumsden A, Waxman J, Bevan CL. Dart DA, et al. Among authors: brooke gn. Oncogene. 2012 Oct 25;31(43):4588-98. doi: 10.1038/onc.2011.591. Epub 2011 Dec 19. Oncogene. 2012. PMID: 22179832 Free PMC article.

4

Structural and functional modelling of SARS-CoV-2 entry in animal models.

Brooke GN, Prischi F. Brooke GN, et al. Sci Rep. 2020 Sep 28;10(1):15917. doi: 10.1038/s41598-020-72528-z. Sci Rep. 2020. PMID: 32985513 Free PMC article.

5

Prohibitin, a protein downregulated by androgens, represses androgen receptor activity.

Gamble SC, Chotai D, Odontiadis M, Dart DA, Brooke GN, Powell SM, Reebye V, Varela-Carver A, Kawano Y, Waxman J, Bevan CL. Gamble SC, et al. Among authors: brooke gn. Oncogene. 2007 Mar 15;26(12):1757-68. doi: 10.1038/sj.onc.1209967. Epub 2006 Sep 11. Oncogene. 2007. PMID: 16964284

6

Characterisation of the androgen regulation of glycine N-methyltransferase in prostate cancer cells.

Ottaviani S, Brooke GN, O'Hanlon-Brown C, Waxman J, Ali S, Buluwela L. Ottaviani S, et al. Among authors: brooke gn. J Mol Endocrinol. 2013 Nov 7;51(3):301-12. doi: 10.1530/JME-13-0169. Print 2013 Dec. J Mol Endocrinol. 2013. PMID: 23997240 Free PMC article.

7

Revising the role of the androgen receptor in breast cancer.

Fioretti FM, Sita-Lumsden A, Bevan CL, Brooke GN. Fioretti FM, et al. Among authors: brooke gn. J Mol Endocrinol. 2014 Jun;52(3):R257-65. doi: 10.1530/JME-14-0030. Epub 2014 Apr 16. J Mol Endocrinol. 2014. PMID: 24740738 Review.

8

Antiandrogens act as selective androgen receptor modulators at the proteome level in prostate cancer cells.

Brooke GN, Gamble SC, Hough MA, Begum S, Dart DA, Odontiadis M, Powell SM, Fioretti FM, Bryan RA, Waxman J, Wait R, Bevan CL. Brooke GN, et al. Mol Cell Proteomics. 2015 May;14(5):1201-16. doi: 10.1074/mcp.M113.036764. Epub 2015 Feb 18. Mol Cell Proteomics. 2015. PMID: 25693800 Free PMC article.

9

The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells.

Leach DA, Mohr A, Giotis ES, Cil E, Isac AM, Yates LL, Barclay WS, Zwacka RM, Bevan CL, Brooke GN. Leach DA, et al. Among authors: brooke gn. Nat Commun. 2021 Jul 1;12(1):4068. doi: 10.1038/s41467-021-24342-y. Nat Commun. 2021. PMID: 34210968 Free PMC article.

10

Mechanisms of androgen receptor repression in prostate cancer.

Powell SM, Brooke GN, Whitaker HC, Reebye V, Gamble SC, Chotai D, Dart DA, Belandia B, Bevan CL. Powell SM, et al. Among authors: brooke gn. Biochem Soc Trans. 2006 Dec;34(Pt 6):1124-7. doi: 10.1042/BST0341124. Biochem Soc Trans. 2006. PMID: 17073766 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

32 results

Search Page